Objective.\p=m-\To determine whether brief, face-to-face educational outreach visits can improve the appropriateness of blood product utilization.
gional variations in medical practice fo¬ cus on the factors that affect physicians' daily clinical decisions. Although one pro¬ posed remedy recently legislated by Con¬ gress is to develop and disseminate prac¬ tice guidelines derived from scientific re¬ search on the outcomes of medical care,1 previous controlled studies of prescrib¬ ing behavior have generally failed to sup¬ port the efficacy of printed educational materials when used alone to improve medical decision making.2·3 Similarly, Lo¬ mas and colleagues4 found that dissemi¬ nation of consensus statements was not effective in reducing repeat cesarean sec¬ tions. On the other hand, several large experiments in the United States and Canada have demonstrated that tar¬ geted, professionally based, face-to-face educational outreach efforts did reduce unnecessary repeat cesarean sections and use of contraindicated or expensive drugs.2·" In this study, we conducted a controlled multicenter trial offace-to-face educational outreach to communicate con¬ cise transfusion guidelines intended to improve the appropriateness of red blood cell (RBC) utilization.
Blood transfusion practice is an impor¬ tant target for guideline implementation When blood is given for appropriate in¬ dications, it can prevent serious illness or death. However, nonindicated use ofblood products can needlessly expose a patient to such risks as the human immunodefi¬ ciency virus, viral hepatitis, increased risk of perioperative bacterial infection,9 fluid overload, and hemolytic transfusion re¬ actions, in addition to the economic costs associated with hospital personnel in¬ volved in processing and transfusing blood and treating adverse effects. Approxi¬ mately 10% of transfusion recipients de¬ velop a troublesome or serious complica¬ tion resulting from a transfusion.10·11 Al¬ though transfusion-associated hepatitis is often subclinical, about 50% of infected patients develop chronic hepatitis, and approximately 10% of these progress to cirrhosis.12
The exact extent of inappropriate use of blood products is not known, but pub¬ lished estimates for RBCs have been as high as 25%.131li While transfusion prac¬ tices may have changed because of an increased awareness of the potential for HIV transmission,8 studies conducted since the onset of the acquired immun¬ odeficiency syndrome (AIDS) epidemic are consistent with earlier work docu¬ menting inappropriate use of blood prod¬ ucts.17·18 Recent reports and clinical guide¬ lines on perioperative RBC transfusion published by the National Institutes of Health and the American College of Phy¬ sicians concluded that inappropriate blood transfusions continue despite widespread concern about overuse of this scarce re¬ source and the potential for transfusioninduced disease.13·19 A survey of 122 surgeons and anes¬ thesiologists in three nonstudy hospitals identified gaps in knowledge and nonclinical factors that affect transfusion de¬ cision making.31 For example, 48% of phy¬ sicians substantially overestimated the probability of inducing a myocardial in¬ farction by withholding blood and allow¬ ing the hematocrit to fall below 30% in the absence of active heart disease and other indications for transfusion. Fortyone percent of surgeons agreed with the misbelief that "a low hematocrit can it¬ self result in impaired postoperative wound healing." In addition, a subgroup analysis suggested that poorer transfu¬ sion knowledge was associated with high¬ er rates of inappropriate transfusions.21
The above findings were used to de¬ sign the educational materials and con¬ tent of a brief, targeted, face-to-face ed¬ ucational outreach program offered by a transfusion-medicine expert in four Mas¬ sachusetts hospitals. We hypothesized that a brief educational visit, conducted one-on-one with physicians who perform transfusions, to discuss gaps in knowl¬ edge identified in the previous survey, would significantly increase the appro¬ priateness of blood product use com¬ pared with physicians not exposed to the program.
METHODS
We used a randomized controlled ex¬ perimental design to measure changes in individual physician compliance with blood transfusion guidelines following the experimental education program. The surgical and medical services in two pairs of matched community and teaching hos¬ pitals in eastern Massachusetts were ran¬ domly assigned to study or control groups. To measure changes in physician practices, all transfusions were analyzed (n=2819 transfusion episodes) for all tar¬ get procedures or diagnoses for controlgroup and study-group physicians for 6 months before (through December 1988) and 6 months following the experimental intervention (through April 1990).
Selection and Randomization
Pairs of teaching and community hos¬ pitals were randomly selected from all hospitals within three health service ar¬ eas in eastern and central Massachusetts.
First, all hospitals were identified that had used at least 3000 U of RBCs and performed over 50 hip repairs (one of the "target" procedures, International Clas¬ sification of Diseases, Ninth Revision [ICD-9] codes 79.35 through 79.3e)22 in 1986 in order to ensure sufficient sample size for analysis. A minimum of 25 RBC transfusions per 100 admissions overall was required to ensure sufficient volume of blood use. After one teaching hospital and one community hospital had been randomly selected from the entire list, a second hospital of each type was ran¬ domly identified from one of the other two health service areas to minimize the risk of experimental contamination due to physicians' practicing at multiple sites within a health service area. All four of the hospitals identified in the first selec¬ tion agreed to participate in the study. One surgical service in each matched pair was then randomly assigned to the study group and the other to the control group; within each hospital the medical service was assigned to the treatment group op¬ posite from surgery.
Patient and Physician Samples
Target surgical procedures were se¬ lected based on the frequency of proce¬ dures, frequency of blood use for the procedures, suspected inappropriate blood use (based on the literature and a pilot study conducted in four nonstudy hospitals), and reasonable medical con¬ sensus on appropriate or inappropriate transfusion practice for such cases. Pro¬ cedures selected for the surgical sample included esophageal surgery and gastrectomy (ICD-9 codes 42.00 through 46.99); cholecystectomy (ICD-9 codes 51.2 through 51.99); large-vessel surgery (ICD-9 codes 38.00 through 39.59 [ex¬ cept 39.27]); repair of hip fracture (ICD-9 codes 79.35 through 79.36), hip and knee replacements (ICD-9 codes 81.40 through 81.69); and discectomy (ICD-9 codes 80.50 and 81.00 through 81.09). Because of small numbers of patients receiving a transfusion in the medicine service, we defined the sample broadly as any admission that did not include a surgical procedure. This led to a much more heterogeneous group of patients in the medical sample than in the sur¬ gical sample.
All staff surgeons in orthopedic, vas¬ cular, and general surgery, and attend¬ ing physicians in the department of med¬ icine were included in the study if they ordered four or more RBC transfusions for target procedures or diagnoses in the 6-month preintervention period.
We identified for audit the medical records of all patients who received trans¬ fusions who underwent one of the tar¬ geted procedures or who met criteria for the medical sample, and who were at¬ tended by one of the study physicians or surgeons. Patients who received over 40 U of blood were excluded, as were those who received transfusions with autologous or intraoperatively salvaged blood. Transfusions were attributed to the attending physician in both the com¬ munity and teaching hospitals, even if the order for blood was generated by a resident in the latter. A previous physi¬ cian survey20 indicated that attending physicians were perceived to be the key decision makers in transfusion decisions, even when they did not actually write the order. If a patient who was admitted for medical reasons subsequently under¬ went a surgical procedure, all transfu¬ sions during the episode of care were attributed to the operating surgeon. Explicit Criteria An audit instrument was designed to measure changes in compliance with a set of explicit criteria, based on the lit¬ erature, published guidelines of the American College of Physicians and ex¬ pert consensus panels,13 and the input of a local panel of surgeons, internists, and experts in transfusion medicine. Briefly, the audit criteria suggested that a trans¬ fusion would be indicated in the presence of a pretransfusion hematocrit of 24% or less, a fall in hematocrit of 6 percentage points or more within 24 hours, or a pre¬ transfusion hematocrit between 24% and 30% in the presence of one of the follow¬ ing: angina within 24 hours prior to trans¬ fusion, myocardial infarction within 6 weeks prior to transfusion, an electro¬ cardiogram indicating acute ischemia or acute infarcì, or blood loss of 1000 mL or greater prior to transfusion. Patients with a pretransfusion hematocrit between 24% and 30% with none of these conditions, but who were either 75 years of age or older or had a history of coronary artery disease were placed in an "indetermi¬ nate" group because of a high degree of disagreement within the medical com¬ munity about the indications for trans¬ fusion in these patients.
The unit of audit was the "transfusion episode," defined as all units of RBCs administered contiguously within a 12hour period. All transfusion episodes were scored against the explicit criteria and classified as compliant, noncompliant, or indeterminate. These categori¬ zations were not intended as an abso¬ lute standard for appropriate practice in any given instance; rather, the audit was used to measure changes in the per¬ formance of groups of physicians over time, based on rates of compliance with explicit criteria derived from clinical guidelines. Likewise, the audit was not intended to identify or provide feedback for individual instances of "inappro¬ priate" practices. The criteria were formulated with the understanding that under certain clinical circumstanc¬ es, noncompliance with guidelines may be completely justified.
The Audit Process Information regarding characteristics of the patient and of each transfusion episode was abstracted from the hospital record by two trained medical record ab¬ stractors, using a computerized data col¬ lection program. Data elements included patient-level descriptive information (eg, age, sex, medical record number, and at¬ tending physician); clinical and operative information (eg, history of prior myocar¬ dial infarction, blood loss during proce¬ dure, and diagnosis and procedure ICD-9 codes); laboratory data (eg, hemoglobin level and hematocrit for the date of ad¬ mission, the date of any procedure, and the dates of and 24 hours before all trans¬ fusions); and information on each RBC unit transfused (eg, date, time, and place). Data were entered by auditors directly into a laptop computer, and later were run through a computer-based algorithm to assess each transfusion episode for compliance with practice guidelines. The use of branching logic and internal con¬ sistency validation in the capture pro¬ grams (eg, transfusion dates within ad¬ mission and discharge dates, hematocrit approximately equal to three times the hemoglobin level) helped to ensure that all relevant information was collected for each case in a standard fashion, and that the information was coherent and logi¬ cal. Reliability was assessed by compar¬ ing the responses of two auditors on 1145 items for 13 transfusion episodes; there was a 92% rate of agreement by auditors on all items abstracted from each record.
Educational Program Content
To maximize program credibility and physician acceptance of educational mes¬ sages, the intervention was created and described as an innovative educational program produced jointly by the Har¬ vard Medical School and the American Red Cross Blood Services, Northeast Re¬ gion. The experimental intervention con¬ sisted of printed materials presenting the transfusion guidelines in a concise and graphic manner, with appropriate refer¬ ences to the clinical literature; one group educational presentation on each service; and a single scheduled, 20- 
Implementation of Intervention
Approximately five half-day sessions were spent with the physician educator (M.A.P.) orienting him to the principles and techniques of interactive communi¬ cation and persuasion used in previous studies through discussion and role play¬ ing.24 These principles included (1) clear¬ ly establishing the credibility ofthe source of the information and the messenger; (2) presenting both sides of controversies; (3) stimulating physician interaction to increase participation and define moti¬ vations for practice; (4) using graphs, il¬ lustrations, and headlines in printed ed¬ ucational materials to convey important messages during educational visits; and (5) repeating and reinforcing the most important behavior-change messages.
The hospital-based service rounds were conducted by the physician educator and consisted of 60-minute sessions, of which approximately 15 minutes were allotted for questions. To avoid contamination of control services, rounds were conducted exclusively for each experimental ser¬ vice. The one-on-one sessions were held at the office of the transfusing physician. Appointments were scheduled in advance by the physician counselor, who informed the physician that the purpose of the visit was educational and that the dura-tion would not exceed 30 minutes. Occa¬ sionally, surgeons mentioned specific an¬ esthesiologists as important influences on transfusion practice; in these few cases, the anesthesiologists were visited as well. During all one-on-one visits, the discussion was confined to transfusion principles; individual data (performance) feedback was not provided.
Statistical Analysis
Because the physician was the primary unit of intervention, all transfusion data were aggregated and analyzed at this lev¬ el. We observed changes between the preintervention and postintervention peri¬ ods in the proportion of transfusion epi¬ sodes in each physician's practice that did or did not meet the criteria. We also mea¬ sured preintervention-to-postintervention changes in the physician-level average pre¬ transfusion hematocrit (the mean of the last recorded hematocrit before each au¬ dited transfusion). We used general lin¬ ear models to evaluate the statistical sig¬ nificance of the experimental condition on observed changes in study outcome vari¬ ables from baseline to follow-up periods, controlling for type of study hospital (com¬ munity vs teaching). These models were of the following form:
Proportionpost=Proportionpri.+Experimental Group<0/1)+Hospital Type(0/1) The interaction between experimental group and hospital type was tested and found to be nonsignificant, demonstrat¬ ing consistency in effects in both ex¬ perimental hospitals; this term was therefore excluded from the models. All proportions were transformed prior to modeling using the arcsine transforma¬ tion to normalize distributions and con¬ trol for boundary effects25; all results were converted back to proportional form for presentation in the text and figures. Re¬ ported F-test values correspond to tests of the significance of the term for exper¬ imental group in these models using type III partial sums of squares.
To avoid selection bias, we used an in¬ tention-to-treat analysis in which physi¬ cians randomized to the intervention group who refused or were unable to schedule one-on-one visits were included in all analyses as members ofthat group. In addition, where appropriate, we plot¬ ted the observed physician-level changes (Proportion11(,st-PiOportionpre) and 95%
confidence intervals by study group to describe the variation in physician re¬ sponses to the intervention. Analyses were conducted separately for surgical and medical services. Excluding indeter¬ minate cases from statistical analysis and considering only transfusions identified as either compliant or noncompliant with guidelines substantially increased the magnitude of observed effects; these in¬ determinate cases are conservatively in¬ cluded in all reported analyses. Table 1 presents background charac¬ teristics of the four study hospitals and physicians who met entry criteria for tar¬ get procedures, diagnoses, and transfu¬ sion rates. Study and control sites were comparable with respect to bed size and number of admissions. The distribution of medical and surgical specialties in the study and control hospitals was similar ( Table 1 ). Orthopedic surgery was the dominant specialty in the physician sam¬ ples of all four hospitals (44% to 56%) because of the high frequency of ortho¬ pedic procedures in the sample and as¬ sociated transfusion rates. Study physi¬ cians were very receptive to the educa¬ tional visits; 80% agreed to meet with the transfusion-medicine specialist, and the mean time per visit ranged from 29 to 31 minutes across the four study hospitals. Figure 1 presents data on the overall effects ofthe experimental education pro¬ gram on rates of compliance with the explicit criteria for all study and control surgeons, and stratified by communityand teaching-hospital settings. These data are based on 1449 transfusion episodes. Rates of compliance and noncompliance are not reciprocal due to the third group of indeterminate transfusions. At base¬ line, the average proportion of transfu¬ sion episodes that were noncompliant with guidelines was comparable across study and control surgeons. After the intervention, the average proportion of noncompliant transfusions declined from 0.40 to 0.24 among study surgeons com¬ pared with an increase from 0.40 to 0.44 among control surgeons (F, 8.32; df 1; P=.006). Conversely, the average pro¬ portion of transfusions that were com¬ pliant rose from 0.22 to 0.43 in the study group, and from 0.29 to 0.32 among con¬ trol surgeons (F, 5.12; P=.03). No differ¬ ence was observed between study and control groups in the average preintervention-to-postintervention change in the proportion oftransfusions that were clas¬ sified as indeterminate.
RESULTS

Program Effects on Compliance
Observed differences between study and control groups were similar for teach¬ ing-and community-hospital surgeons (Fig 1) , suggesting that the experimen¬ tal intervention was equally likely to al¬ ter practice patterns in both communityand teaching-hospital settings.
Because of the limited number of study hospitals and the possibility that differ¬ ences in case-mix and specialty distribu¬ tions could confound observed differ- "Classification of study and control groups was based on assignment of surgical services; medical services in each hospital were assigned to the opposite category. enees in practice patterns, we conducted an additional analysis of differences be¬ tween study and control physicians in the largest homogeneous subgroup of physi¬ cians, orthopedic surgeons (50% of sur¬ geons). This subgroup analysis confirmed the effects observed in the overall sam¬ ple. The average proportion of transfu¬ sions that were noncompliant with guide¬ lines declined from 0.30 before the inter¬ vention to 0.16 after the intervention among study orthopedic surgeons, com¬ pared with an increase from 0.29 to 0.43 among orthopedic surgeons in control ser¬ vices (F, 6.31; P=.02).
Physician-Level Changes in Practice
The means and distributions of prac¬ tice-specific changes (from preintervention to postintervention) in the propor¬ tion of transfusions that were noncom¬ pliant or compliant with guidelines are presented by study group in Fig 2. The data suggest that the observed changes in physician practices were not concen¬ trated among a few "outliers." In fact, 74% of study physicians reduced the pro¬ portion of transfusions that were noncompliant, compared with only 35% of control surgeons. The same pattern of physician-level changes was observed for transfusions that were compliant.
Changes in Hematocrit Thresholds
We considered the possibility that the observed differences in compliance rates could reflect the quality of documentation of transfusion indications rather than dif¬ ferences in the quality of practice. Rou¬ tinely collected laboratory data on pretransfusion hematocrit, the most impor¬ tant element in the explicit criteria, are not subject to this recording bias, and thus represent a more objective measure of the impact of the intervention. Since a principal educational message was that Changes were calculated as physician-specific preintervention-topostintervention differences in the proportions of transfusions given for target cases (n=40 surgeons, 1449 audited transfusions). A negative change indicates a reduction; a positive change, an increase. Boxes de¬ note the 95% confidence limits around the mean change for each group (represented by the horizontal lines). Mean changes were based on raw physician-level data, and therefore differ slightly from means reported elsewhere in the text that are based on transformed data used in the general linear model analysis.
traditional hematocrit thresholds for transfusion (eg, 30%), ifused at all, should be lowered to hematocrit of 27% or less in uncomplicated hemodynamically stable patients, another measure of the success of the educational intervention is the change in pretransfusion hematocrit with¬ in study and control surgical practices. The data provide evidence that the inter¬ vention lowered the transfusion "trigger" substantially among study surgeons. At baseline, the average pretransfusion he¬ matocrit (the mean ofindividual surgeons' average hematocrit for their total audited caseload) was virtually identical for study (28.3%) and control (28.3%) surgeons, and for community (28.3%) and teaching (28.2%) hospitals. After the intervention, the average pretransfusion hematocrit de¬ clined by 2.0 percentage points to 26.3% among study surgeons, while remaining at 28.3% among controls (average preintervention-to-postintervention change, -1.9 percentage points for study physi¬ cians and +0.01 percentage points for con¬ trol physicians; Student's t test, 2.11; P=.04). This change was not due to an increase in the number of pretransfusion hematocrit determinations ordered; for ex¬ ample, among study surgical cases, this frequency dropped slightly from an av¬ erage of 2.5 (preintervention) to 2.2 (postintervention), compared with 2.7 (preintervention) to fective, and nonregulatory strategies to improve blood transfusion decisions. Our data indicate that a brief and relatively inexpensive educational outreach pro¬ gram involving one personal visit by a transfusion specialist, concise guidelines, and one group seminar can increase ad¬ herence to guidelines on the use of RBCs in surgical patients. The intervention re¬ sulted in a clinically and statistically sig¬ nificant decrease in noncompliant trans¬ fusions in comparison with controls. More importantly, the program reduced the average pretransfusion hematocrit, the most objective measure of change in prac¬ tice pattern, from 28.3% to 26.3% among study surgeons, with no change observed among controls. All effects were constant across teaching and community hospi¬ tals, and across surgical specialty. The lack of effect on the medical services may have been due in large part to low num¬ bers of transfusions, much lower hemat¬ ocrit in comparison with surgery, and a more heterogeneous patient population.
Although the consistency of interven¬ tion-control differences in physicianlevel changes in transfusion practice supports the internal validity of our find¬ ings, the limited number of hospitals in¬ cluded in the study may limit its generalizability. The above data suggest that surgical practice may represent a costeffective target for educational programs to improve blood transfusion practice. Because we did not audit nontransfused cases, it is difficult to address the possibility of undertransfusion, which might have occurred as a result of the educational intervention. However, there is little evidence to support the existence of such a problem. Furthermore, Table 2 suggests that surgeons generally did not wait (either before or after the interven¬ tion) until hematocrits were very low (under 24%) before transfusing. Another unanswered question is whether the changes observed in clinical decision making are durable beyond 6 months of follow-up. Because of the high cost of collecting patient-level chart and laboratory data for thousands of patients, few studies in the clinical decision-mak¬ ing literature have attempted follow-up periods beyond 6 months or 1 year. One exception is a study by Ray and col¬ leagues,20 which found that a similar phy¬ sician "counselor" intervention was ef¬ fective in reducing use of contraindicated antibiotics. Nevertheless, more work is needed to determine the dura¬ tion of the effects of such interventions as well as the need for follow-up rein¬ forcement visits to maintain such effects.
Future studies should also attempt to identify the most important mechanisms or processes of change. For example, what perceptions of risks among study physicians were most affected by the in-tervention and accounted for the great¬ est change in behavior? Our preintervention surveys indicated that overconcern for risks of undertransfusion (eg, myocardial infarction) was responsible for a considerable number of transfusions when the hematocrit was only slightly below 30%. However, most physicians overestimated the risks of transfusionrelated hepatitis and AIDS. While we believe that the careful targeting of the surgeons' concerns regarding undertrans¬ fusion may have been a key factor in the success of the intervention, we also em¬ phasized the major risks of overtransfusion as well; thus, it is not possible to determine which messages were most important in effecting change.
Although a formal cost-benefit analy¬ sis is beyond the scope of this report, preliminary data suggest that programs of direct education of active surgeons would produce net savings. In our study, surgeons transfused an average of 55.8 U per year for target cases at a cost of approximately $11160 (at $200 for ac¬ quiring, handling, testing, and adminis¬ tering each unit). 27 Assuming conserva¬ tively that the intervention reduced over-all transfusion rates by only 10% for 1 year (after which effects were assumed to decay immediately to 0%), and that transfusion-medicine specialists can vis¬ it three physicians per day, the esti¬ mated savings generated from each day of educational visits (approximately $3300) are about four times greater than the daily direct cost (about $750 for sal¬ ary and benefits, travel, and educational materials). Assuming much lower sav¬ ings would still yield substantial net eco¬ nomic benefits. These estimates are con¬ servative, since they exclude likely sav¬ ings in surgeons' practice outside the study hospital, lower rates of transfusion for nontargeted cases, reduced costs of infections and transfusion complications, and health benefits due to increased ap¬ propriateness of blood use.
Our findings suggest that blood-col¬ lection agencies and hospitals might col¬ laborate in the adoption of such innova¬ tions. Not only do savings from reduced blood transfusion appear to exceed the costs of an operational program, but also more appropriate transfusions would lead to less risk to patients and provide bet¬ ter allocation of this scarce resource.
